Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm,…
Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which…
In total, 7.7 million shares were placed at a price of SEK 57.50 per share, corresponding to a total…
